Active Ingredient Blinatumomab
Active Ingredient Details
What is Blinatumomab?
a single-chain bispecific recombinant antibody from Micromet's BiTE (bispecific T-cell engager) product platform that binds both the CD19 antigen and the T-cell receptor (CD3), for the potential treatment of B-cell lymphoma
What is the usage for Blinatumomab?
This medication is used to treat a certain type of cancer (acute lymphocytic leukemia-ALL). Blinatumomab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.
How many products in the NDC database contain Blinatumomab?
The NDC database has 1 products with the active ingredient Blinatumomab. The following table lists all the products that have this active ingredient.
NDC Products with Blinatumomab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 17504-0011 | Proprietary Name: | Blinatumomab | Liquid | Lonza Biologics, Plc | ACTIVE |
